Brandon May

A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.

Patients with asthma who depend on oral corticosteroids (OCS) may be able to reduce the dependence or eliminate the use of OCS altogether with benralizumab.

Treatment with trimethoprim-sulfamethoxazole was associated with improvements in lung function and decreased visits to the emergency department among children with asthma.

Budesonide oral suspension improved histologic, endoscopic, and both histologic and symptomatic outcomes in children with eosinophilic esophagitis compared with placebo.

A single dose of PHA-022121, an oral beta-2 antagonist, was associated with effective bradykinin-inhibiting concentrations within 15 minutes of administration in patients with hereditary angioedema.

Researchers evaluated the potential predictive characteristics of eosinophilic esophagitis following IBD diagnosis in children.

Treatment with omalizumab was associated with sleep improvements in patients with chronic rhinosinusitis with nasal polyps.

Heart rate, respiratory rate, and oxygen saturation (SpO2) levels with percentile-based cutoffs can predict the risk of prolonged hospitalization in pediatric asthma exacerbations.

Patients with asthma that is poorly controlled by ICS/LABA therapy may experience improvement in lung function with the addition of umeclidinium and/or doubling of the corticosteroid fluticasone furoate.

Adding reslizumab to mometasone furoate enhanced clinical benefits of the intranasal corticosteroid alone in patients with uncontrolled chronic rhinosinusitis with nasal polyps and peripheral eosinophilia.